Align Technology | ALGN - Ebitda


Align Technology reported $229.14M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
3M USD 1.66B 239M Jun/2026
Align Technology USD 229.14M 31.74M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Henry Schein USD 288M 1000K Jun/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
McKesson USD 1.88B 206M Dec/2025
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Solventum Corp USD 437M 0 Mar/2026
Stryker USD 1.93B 357M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Veeva Systems USD 403.96M 29.17M Mar/2026
Waters USD 712M 545M Jun/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 939M 101M Dec/2025